Aurobindo Pharma Issues Nationwide Recall of Migraine Relief Tablets Due to Mislabeling

Aurobindo Pharma USA, Inc. has issued a voluntary nationwide recall of its Healthy Living Migraine Relief tablets due to serious mislabeling issues that could endanger consumer health. Sold primarily through Amazon, these acetaminophen, aspirin, and caffeine tablets lack essential over-the-counter labeling, raising concerns about safe usage. Consumers are urged to check their medicine cabinets and discontinue use if they have purchased the affected product. Stay informed about medication recalls to protect your health.